Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00016600
DRKS00016600
Recruiting
Not Applicable

Evaluation of a novel test to detect subtle cognitive deficits in relapsing-remitting Multiple Sclerosis - EARLY COGDYS IN MS 001

Medizinische Fakultät Carl Gustav Carus0 sites210 target enrollmentFebruary 12, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsG35Multiple sclerosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G35
Sponsor
Medizinische Fakultät Carl Gustav Carus
Enrollment
210
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 12, 2019
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Medizinische Fakultät Carl Gustav Carus

Eligibility Criteria

Inclusion Criteria

  • •1\. CIS or newly diagnosed MS patients (McDonald criteria). Diagnosis \< 4 months
  • •2\. stable RRMS patients. Diagnosis \< 48 months, stable immunomodulatory therapy \> 6 months, no relapses within 6 months.
  • •3\. SPMS patients. Start of treatment \< 20 years, EDSS \< 6\.5 and no relapses within 6 months.
  • •Age between 18 and 50 years

Exclusion Criteria

  • •Other neurological pre\-existing conditions other than MS
  • •\- Psychiatric disorders
  • •\- Occurrence of learning disorders, severe head injuries, substance abuse, epilepsy
  • •\- Corticosteroid intake within 4 weeks before study participation
  • •\- Non\-correctable hearing and visual impairments

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Evaluating a novel diagnostic test for the detection of Plasmodium infections at community level in The Gambia and Burkina FasoDiagnosis of Plasmodium infectionInfections and Infestations
ISRCTN15263932MRC Unit The Gambia at LSHTM1,900
Not yet recruiting
Not Applicable
Development of a new screening test of measure lower extremity agility to attempt to regain standing balance to avoid falls
JPRN-UMIN000044709Japan Community Health care Organization Chukyo Hospital220
Recruiting
Not Applicable
Evaluation of diagnostic test for the superficial bladder cancer based intravesical instillation of pirarubicin (THP) prior to transurethral resection (TUR)Superficial bladder cancer
JPRN-UMIN000018932Dokkyo Medical University, Department of Urology30
Recruiting
Not Applicable
A study to determine the ability of a blood test for B-type Natriuretic Peptide signal peptide (BNP-SP) to act as an early indicator in Acute Coronary Syndrome (ACS)).
ACTRN12609000057280Health Research Council of New Zealand2,000
Recruiting
Not Applicable
Validation study of a new quantitative sensory testing device &quot;intercross-220&quot;
JPRN-UMIN000045701Others30